Evaluation of current therapeutic strategies in Behçet's disease.
Behçet's disease (BD) is a chronic relapsing vasculitis with multifunctional pathogenesis. The mucocutaneous and ocular lesions are the commonest manifestations, but BD also affects the musculoskeletal, intestinal, cardiac, and central nervous system. BD therapy is based on the suppression of the inflammatory process, using immunomodulating and immunosuppressive agents. In selected cases, invasive procedures may be required.
Alexoudi
Iliana
I
First Department of Internal Medicine, University of Athens, Laikon Hospital, 69 Vosporou Str, Athens, 10444, Greece. aleiliana@yahoo.gr
Kapsimali
Violetta
V
Vaiopoulos
Aristides
A
Kanakis
Meletios
M
Vaiopoulos
George
G
D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D056747:Immunomodulation; D007166:Immunosuppressive Agents / Q000627:therapeutic use*
D007166:Immunosuppressive Agents